Skip to main content
Clinical Trials/NCT01522079
NCT01522079CompletedNot Applicable

Spinal Muscular Atrophy and Cardiac Autonomic Function

Centro Universitário Augusto Motta0 sites9 target enrollmentStarted: January 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
9
Primary Endpoint
Cardiac autonomic function

Study Overview

Brief Summary

Respiratory dysfunction is the major cause of morbidity and mortality in patients with spinal muscular atrophy (SMA). Air stacking is a clearance airway technique frequently used but its effects on cardiac autonomic function in patients with spinal muscle atrophy is not clear.

Objective: To evaluate the acute effect of air stacking and posture on cardiac autonomic function in patients with spinal muscular atrophy types II and III.

Methods: Patients with spinal muscle atrophy type II and III will be recruited. Electrocardiogram signals will be recorded for analyses of heart rate variability during air stacking in supine and sitting position.

Detailed Description

Background: Respiratory dysfunction is the major cause of morbidity and mortality in patients with spinal muscular atrophy. Air stacking is a clearance airway technique frequently used but its effects on cardiac autonomic function in patients with spinal muscle atrophy is not clear.

Objective

To evaluate the acute effect of air stacking and posture on cardiac autonomic function in patients with spinal muscular atrophy types II and III.

Methods: Patients with spinal muscle atrophy type II and III will be recruited. Electrocardiogram signals will be recorded for analyses of heart rate variability during air stacking in supine and sitting position. Data will collected before, during and after air stacking and will be compared using Anova Repeated Measures or Kruskal-Wallis Anova on Ranks, followed by Tukey test. The relationship between heart rate variability indexes and age will be evaluated by Pearson correlation. Significant level will be set at 5%.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • diagnosis of SMA types II and III,
  • absence of acute respiratory disease in the last two weeks,
  • agreement to participate in the study,
  • according written informed consent and
  • at least 5 years old.

Exclusion Criteria

  • respiratory disease in the last two weeks

Outcomes

Primary Outcomes

Cardiac autonomic function

Time Frame: Thirty minutes during air stacking manuever

Evaluation of heart rate variability in patients with spinal muscular atrophy

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Centro Universitário Augusto Motta
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Cristina Marcia Dias

Professor DSc

Centro Universitário Augusto Motta

Similar Trials

Spinal Muscular Atrophy and Cardiac... | Clinical Trial